VACCINE TECHNOLOGY PLATFORMS

Numerous vaccine technology platforms evolved over the past few decades. Today, addressing disease outbreaks and protecting the immuno-compromized provides population severe challenges and at the same time harbors significant growth potential.

Traditional whole-pathogen vaccine platforms, which require the cultivation of the pathogen, have a proven track record for many diseases. The newer generation of vaccine platforms like recombinant protein and the new era of nucleic acid-based vaccines solely need the pathogen’s genetic sequence. By significantly increasing the speed of development and manufacturing processes they open up new potential for a plethora of indications and a vaccine development process in a speed that has never been achieved before.

Inactivated Vaccine / Live-attenuated vaccine

Traditional vaccines: Inactivated and live-attenuated vaccines

Whole inactivated vaccines, first introduced in 1869 for typhoid, still carry the full repertoire of immunogenic components of the original pathogen.

Discover more

Strong growing vaccines: Recombinant protein vaccines

Protein subunit vaccines as for influenza or hepatitis B and C are a proven strategy for decades and still today in the spotlight for pandemic management.

Discover more

The most novel vaccines: Nucleic acid vaccines

Nucleic acid vaccines are made up of mRNA or plasmid DNA encoding antigens which are expressed inside the host cells. Especially mRNA vaccines showed their potential during the recent pandemic and numerous future applications remain to be explored.

Discover more

It All Started in 1500 BC

The history of vaccination begins with the fight against smallpox as early as 1500 BC. Chinese doctors ground up pieces of smallpox crust from infected people into a powder that was administered as a snuffing agent. People from Asia and Europe immunized themselves by transferring the vesicular contents of smallpox to healthy people.

Start your time travel

Level up your vaccine research with Eppendorf technologies and read our solutions for pharma vaccines. Eppendorf’s best-fit solutions with carefully selected tools for automation are tailored to the individual needs of your vaccine-development workflow. Let us support you to get your vaccine to market faster!

Download eBook

Service technician in vaccine research laboratory

Supporting you – maintenance and qualification services

With our basket of Service and Extended Warranty Agreement solutions we take the load off your shoulders by simplifying your ordering and budgeting process for various services over the full lifetime of your instruments. Your costs become reduced and predictable, thereby assuring continuous productivity and a long service life.

Discover more

Sustainability can only be achieved in collaboration

The fundamental principle of sustainability has always played a role at our company since its founding in 1945. Within the Eppendorf Group, our goal is to continue to grow and develop so that we do not exceed the bounds of our planet’s resilience now or in the future, and to ensure that our actions are aligned with society’s needs.

Discover more

Best fit solutions for researching the next life saving vaccine

Today's vaccines must meet stringent quality standards and must be developed and manufactured quickly and cost-effectively. Eppendorf’s best fit solutions with carefully selected tools are tailored to the individual needs of your vaccine development workflow.

Download brochure